MedPath

Pelvic Floor Muscle Training and Hypopressive Exercises for Pelvic Organ Prolapse

Not Applicable
Conditions
Pelvic Organ Prolapse
Registration Number
NCT01196598
Lead Sponsor
Federal University of São Paulo
Brief Summary

To verify if pelvic floor muscle training program and/or a hypopressive exercise program could improve women with stage II of pelvic organ prolapse, their symptoms or pelvic floor muscle strength.

Detailed Description

To verify if three months of an exercise program could improve stage II of pelvic organ prolapse, as a conservative treatment.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
84
Inclusion Criteria
  • women with stage II of pelvic organ prolapse, preferably symptomatic and not to be submitted to surgery to correct pelvic organ prolapse during the study
Exclusion Criteria
  • Neuromuscular diseases and use of hormonal therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pelvic floor muscle changes3 months after the begining of treatment

Digital palpation - Evaluates the pelvic floor muscle contraction and assign values according to scales: Oxford (previously validated) and muscular endurance (measured in seconds)

Surface electromyography - evaluates the electrical activity generated by activation of motor units of pelvic floor muscles - during the rest and during the maximum voluntary contraction

2D perineal ultrasound - evaluates the cross sectional area of levator ani muscle.

Secondary Outcome Measures
NameTimeMethod
Pelvic Organ Prolapse changes3 months after the begining of treatment

Quantification of stage of pelvic organ prolapse. Measured during gynecology exam by pelvic organ prolapse quantification (POP-Q)exam.

Measure of changes in symptoms of pelvic organ prolapse using a questionnaire.

Trial Locations

Locations (1)

Federal University of São Paulo

🇧🇷

São Paulo, Brazil

Federal University of São Paulo
🇧🇷São Paulo, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.